Gel for the treatment of herpes lip lesions

Evaluation of precursory gel of film containing on-site anesthetic for treatment of the herpes simplex: randomized, double-blind and controlled clinical study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-4kkq8c

Enrollment

Unknown

Registered

2018-09-10

Start date

2017-03-10

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpetic Stomatitis

Interventions

A total of 90 patients are being selected to participate in the survey and photographic lesions were taken for initial registration. The clinical application of the film precursor semisolid compositio

Drug

Device

D27.505.954.122.388

D20.215.894.899.290

Eligibility

Age

10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Legal or minor adult volunteers with accompanying legal guardians; both genders; without current treatment regimen against herpes.

Exclusion criteria

Exclusion criteria: Individuals in use or who used systemic-specific antiviral medication in the 15 days preceding the study;pregnant women;patients with heart disease.

Design outcomes

Primary

Measure	Time frame
It is expected that patients treated with the application of the film-forming semisolid composition will benefit from the remission of signs and symptoms of herpes labialis lesions within 24 to 72 hours after initiation of treatment.	—

Secondary

Measure	Time frame
Secondary outcomes are not expected	—

Countries

Brazil

Contacts

Public ContactVinicius Pedrazzi

Faculdade De Odontologia de Ribeirão Preto

pedrazzi@forp.usp.br+55 16 3315-4008

Outcome results

None listed

Source: REBEC (via WHO ICTRP)